** = Publikationen gelistet in SCI/SSCI/Pubmed
** Haas, D; Pikal, SR; Galler, H; Habib, J; Moser, T; Ofner-Kopeinig, P; Schalli, M
Particulate matter and airborne microorganisms in a construction site in Graz, Austria
ATMOS ENVIRON. 2025; 344: 121025
Doi: 10.1016/j.atmosenv.2024.121025
Web of Science
FullText
FullText_MUG
** Hafner, T; Stadlbauer, S; Schalli, M
Ferrocene functionalized oligomeric siloxane building blocks as potential linkers for biological active molecules
INORG CHEM COMMUN. 2024; 162: 112203
Doi: 10.1016/j.inoche.2024.112203
Web of Science
FullText
FullText_MUG
** Ziegler, HP; Platzer, S; Haas, D; Galler, H; Schalli, M
Protocol for inoculating bottled mineral water with bacteria to receive artificial contaminated water samples.
STAR Protoc. 2024; 5(2): 103026
Doi: 10.1016/j.xpro.2024.103026
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Haas, D; Ilieva, M; Fritz, T; Galler, H; Habib, J; Kriso, A; Kropsch, M; Ofner-Kopeinig, P; Reinthaler, FF; Strasser, A; Zentner, E; Schalli, M
Background concentrations of airborne, culturable fungi and dust particles in urban, rural and mountain regions.
Sci Total Environ. 2023; 892:164700
Doi: 10.1016/j.scitotenv.2023.164700
Web of Science
PubMed
FullText
FullText_MUG
** Schalli, M; Kogler, B; Miorini, T; Gehrer, M; Reinthaler, FF
High-Speed Dental Instruments: An Investigation of Protein-Contaminated Dental Handpieces with the Bicinchoninic Acid Assay in Dental Offices in Styria, Austria.
Int J Environ Res Public Health. 2023; 20(3):
Doi: 10.3390/ijerph20031670
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Schalli, M; Platzer, S; Haas, D; Reinthaler, FF
The behaviour of Escherichia coli and Pseudomonas aeruginosa in bottled mineral water.
Heliyon. 2023; 9(11): e21634
Doi: 10.1016/j.heliyon.2023.e21634
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schalli, M; Platzer, S; Schmutz, R; Ofner-Kopeinig, P; Reinthaler, FF; Haas, D
Dissolved Carbon Dioxide: The Lifespan of Staphylococcus aureus and Enterococcus faecalis in Bottled Carbonated Mineral Water.
Biology (Basel). 2023; 12(3):
Doi: 10.3390/biology12030432
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schalli, M; Inwinkl, SM; Platzer, S; Baumert, R; Reinthaler, FF; Ofner-Kopeinig, P; Haas, D
Cefsulodin and Vancomycin: A Supplement for Chromogenic Coliform Agar for Detection of Escherichia coli and Coliform Bacteria from Different Water Sources.
Microorganisms. 2022; 10(12):
Doi: 10.3390/microorganisms10122499
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kyri, AW; Schuh, L; Knoechl, A; Schalli, M; Torvisco, A; Fischer, RC; Haas, M; Stueger, H
Sila-Peterson Reaction of Cyclic Silanides.
Organometallics. 2020; 39(10): 1832-1841.
Doi: 10.1021/acs.organomet.0c00106
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Weber, P; Thonhofer, M; Averill, S; Davies, GJ; Santana, AG; Müller, P; Nasseri, SA; Offen, WA; Pabst, BM; Paschke, E; Schalli, M; Torvisco, A; Tschernutter, M; Tysoe, C; Windischhofer, W; Withers, SG; Wolfsgruber, A; Wrodnigg, TM; Stütz, AE
Mechanistic Insights into the Chaperoning of Human Lysosomal-Galactosidase Activity: Highly Functionalized Aminocyclopentanes and C-5a-Substituted Derivatives of 4-epi-Isofagomine.
Molecules. 2020; 25(17):
Doi: 10.3390/molecules25174025
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wolfsgruber, A; Thonhofer, M; Weber, P; Nasseri, SA; Fischer, R; Schalli, M; Stütz, AE; Withers, SG; Wrodnigg, TM
N-Alkylated Iminosugar Based Ligands: Synthesis and Inhibition of Human Lysosomal β-Glucocerebrosidase.
Molecules. 2020; 25(20):
Doi: 10.3390/molecules25204618
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schalli, M; Weber, P; Nasseri, SA; Gomez, AT; Muller, P; Stutz, AE; Withers, SG; Wolfsgruber, A; Wrodnigg, TM
Biologically active branched-chain aminocyclopentane tetraols from d-galactose
MONATSH CHEM. 2019; 150(5): 861-870.
Doi: 10.1007/s00706-019-02428-0
Web of Science
FullText
FullText_MUG
** Zoidl, M; Wolfsgruber, A; Schalli, M; Nasseri, SA; Weber, P; Stütz, AE; Withers, SG; Wrodnigg, TM
Synthesis of modified 1,5-imino-d-xylitols as ligands for lysosomal β-glucocerebrosidase.
Monatsh Chem. 2019; 150(5): 831-842.
Doi: 10.1007/s00706-019-02427-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lebl, R; Thonhofer, M; Tysoe, C; Pabst, BM; Schalli, M; Weber, P; Paschke, E; Stütz, AE; Tschernutter, M; Windischhofer, W; Withers, SG
A Morita-Baylis-Hillman based route to C-5a-chain-extended 4-epi-isofagomine type glycosidase inhibitors.
Carbohydr Res. 2017; 442(15):31-40
Doi: 10.1016/j.carres.2017.03.003
Web of Science
PubMed
FullText
FullText_MUG
** Schalli, M; Tysoe, C; Fischer, R; Pabst, BM; Thonhofer, M; Paschke, E; Rappitsch, T; Stütz, AE; Tschernutter, M; Windischhofer, W; Withers, SG
N-Substituted 5-amino-1-hydroxymethyl-cyclopentanetriols: A new family of activity promotors for a GM1-gangliosidosis related human lysosomal β-galactosidase mutant.
Carbohydr Res. 2017; 443-444(15):15-22
Doi: 10.1016/j.carres.2017.03.009
Web of Science
PubMed
FullText
FullText_MUG
** Schalli, M; Weber, P; Tysoe, C; Pabst, BM; Thonhofer, M; Paschke, E; Stütz, AE; Tschernutter, M; Windischhofer, W; Withers, SG
A new type of pharmacological chaperone for GM1-gangliosidosis related human lysosomal β-galactosidase: N-Substituted 5-amino-1-hydroxymethyl-cyclopentanetriols.
Bioorg Med Chem Lett. 2017; 27(15):3431-3435
Doi: 10.1016/j.bmcl.2017.05.086
Web of Science
PubMed
FullText
FullText_MUG
** Schalli, M; Wolfsgruber, A; Gonzalez Santana, A; Tysoe, C; Fischer, R; Stütz, AE; Thonhofer, M; Withers, SG
C-5a-substituted validamine type glycosidase inhibitors.
Carbohydr Res. 2017; 440-441(15): 1-9.
Doi: 10.1016/j.carres.2017.01.006
Web of Science
PubMed
FullText
FullText_MUG
** Schalli, M; Thonhofer, M; Wolfsgruber, A; Weber, H; Fischer, R; Saf, R; Stütz, AE
From secondary alcohols to tertiary fluoro substituents: A simple route to hydroxymethyl branched sugars with a fluorine substituent at the branching point.
Carbohydr Res. 2016; 436(15): 11-19.
Doi: 10.1016/j.carres.2016.10.013
Web of Science
PubMed
FullText
FullText_MUG
** Thonhofer, M; Gonzalez Santana, A; Fischer, R; Torvisco Gomez, A; Saf, R; Schalli, M; Stütz, AE; Withers, SG
5-Fluoro derivatives of 4-epi-isofagomine as D-galactosidase inhibitors and potential pharmacological chaperones for GM1-gangliosidosis as well as Fabry's disease.
Carbohydr Res. 2016; 420(5): 6-12.
Doi: 10.1016/j.carres.2015.10.009
Web of Science
PubMed
FullText
FullText_MUG
** Thonhofer, M; Weber, P; Gonzalez Santana, A; Tysoe, C; Fischer, R; Pabst, BM; Paschke, E; Schalli, M; Stütz, AE; Tschernutter, M; Windischhofer, W; Withers, SG
Synthesis of C-5a-substituted derivatives of 4-epi-isofagomine: notable β-galactosidase inhibitors and activity promotors of GM1-gangliosidosis related human lysosomal β-galactosidase mutant R201C.
Carbohydr Res. 2016; 429(15):71-80
Doi: 10.1016/j.carres.2016.03.020
Web of Science
PubMed
FullText
FullText_MUG
** Thonhofer, M; Weber, P; Santana, AG; Fischer, R; Pabst, BM; Paschke, E; Schalli, M; Stütz, AE; Tschernutter, M; Windischhofer, W; Withers, SG
Synthesis of C-5a-chain extended derivatives of 4-epi-isofagomine: Powerful β-galactosidase inhibitors and low concentration activators of GM1-gangliosidosis-related human lysosomal β-galactosidase.
Bioorg Med Chem Lett. 2016; 26(5):1438-1442
Doi: 10.1016/j.bmcl.2016.01.059
Web of Science
PubMed
FullText
FullText_MUG